Robotic Exoskeleton Assisted Gait Post Stroke
Launched by KESSLER FOUNDATION · Mar 12, 2020
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The purpose of this research study is to assess whether using a wearable device, called the robotic exoskeleton (RE), can be helpful in improving recovery of walking in adults who have recently had a stroke. The study will compare the walking abilities of people who went through standard of care treatment after a stroke to those who used the robotic exoskeleton as part of their rehabilitation. This study will also look at the effects walking in the RE has on brain activity. The name of the robotic exoskeleton that is being used in this study is the EksoTM.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stroke survivors \< 4 weeks from most recent stroke.
- • Age: 21- 80 years
- • Unilateral hemiparesis
- • Medical clearance by the Medical Director
- • Be able to physically fit into the exoskeleton device.
- • Have joint range of motion within normal functional limits for ambulation.
- • Have sufficient strength to use the hemiwalker, cane or walker (etc. assistive device) while wearing the RE.
- • Patient cognitive status and ability to communicate in English must be at a level consistent with that required to participate in standard motor rehabilitation, e.g. can follow directions.
- • Adequate cognitive function to give informed consent, understand the training, instructions, use investigational devices and give adequate feedback.
- • No history of injury or pathology to the unaffected limb.
- • physically fit within the RE: Height below 60" or above 76" and weight above 220 lbs.
- Exclusion Criteria:
- • Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity).
- • Skin issues that would prevent wearing the device.
- • Pre-existing condition that caused exercise intolerance.(Documented uncontrolled hypertension, coronary artery disease, cardiac arrhythmia, or congestive heart failure)
- • Hospitalization for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study.
- • Severe cognitive or psychiatric problems as well as incontinence might be contraindications to start training with a RE.
- • History of severe cardiac disease such as myocardial infarction, congestive heart failure
- • Uncontrolled seizure disorder.
- • Uncontrolled spasticity or joint contracture that would interfere with walking in the RE and limits normal ROM during ambulation with assistive devices.
- • Neuromuscular or neurological pathologies (e.g., Parkinson's disease, spinal cord injury, or traumatic brain injury with evidence of motor weakness and multiple sclerosis) that will interfere with neuromuscular function, ambulation, or limit the range of motion of the lower limbs
- • Orthopedic pathologies or history that will interfere with ambulation or limit the ROM of the lower limbs (e.g., knee replacement, fixed contractures, inflammation)
- • Any metal implants that are NOT MRI-compatible
About Kessler Foundation
Kessler Foundation is a leading nonprofit organization dedicated to advanced rehabilitation research and the development of innovative strategies to improve the lives of individuals with disabilities. With a strong emphasis on clinical trials and evidence-based practices, the Foundation collaborates with academic institutions, healthcare providers, and industry partners to explore novel therapeutic approaches and technologies. Its commitment to enhancing mobility, cognitive function, and overall quality of life for people with neurological and musculoskeletal conditions drives its mission to transform rehabilitation outcomes through cutting-edge research and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
West Orange, New Jersey, United States
Patients applied
Trial Officials
Karen J. Nolan, PhD
Principal Investigator
Kessler Foundation
Soha Saleh, PhD
Principal Investigator
Kessler Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials